Research News and Research

RSS

Medicaid enrollment at late stages may partly explain poor outcomes for cancer

A new study concludes that the unavailability of health insurance prior to Medicaid enrollment may contribute to poor outcomes in the Medicaid-insured cancer population.

9 Mar 2005

Telomerase finding has major implications for cancer

UCLA biochemists have determined the three-dimensional structure of a major domain of telomerase, the enzyme that helps maintain telomeres - small pieces of DNA on the ends of chromosomes that act as protective caps - allowing DNA ends to be copied completely when cells are replicated.

9 Mar 2005

Overlapping signals in embryo help get the backbone right

A major step in the development of the vertebrate embryo - the establishment of a back that morphs into a brain, spinal cord and muscles - turns out to be so important that the body uses at least three signals to make sure it happens properly.

9 Mar 2005

Finding may open new horizons for understanding the initiation of chemically induced cancers

A team from the chemistry and biology departments of New York University, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), has uncovered a conformational switch - a change in shape in a carcinogen-damaged DNA site - in tumor suppressor genes altered by a known cancer-causing chemical found in cigarette smoke.

9 Mar 2005

New chemotherapy gives hope to brain tumour patients

A large international study conducted by the European Organisation for Research and Treatment of Cancer (EORTC) in collaboration with the National Cancer Institute of Canada (NCIC) Clinical Trials Group demonstrated that the addition of a novel chemotherapy agent, Temozolomide (brand name: Temodal®) to radiation therapy increases survival in patients suffering from glioblastoma, a very aggressive form of a brain tumour.

9 Mar 2005

Efforts to improve the quality of post-heart attack care working better for men than for women

Efforts to improve the quality of post-heart attack care in hospitals are working - but they appear to be working better for men than for women, new research shows.

9 Mar 2005

First reliable measure of neurobehavioral functioning during coma from severe brain injury

A Northwestern University researcher has developed the first truly reliable measure of neurobehavioral functioning during coma from severe brain injury that predicts recovery of consciousness up to one year after injury, with up to 86 percent certainty.

9 Mar 2005

Commonly used anesthetic regimen appears to have no negative effects on the developing brain of the fetus

An anesthetic regimen commonly used during surgery on pregnant mothers appears to have no negative effects on the developing brain of the fetus, according to a new study on sheep conducted by Duke University Medical Center researchers.

9 Mar 2005

Common anesthetics appear safe for developing fetal brain

A group of Dartmouth researchers has learned that the brain's auditory cortex, the part that handles information from your ears, holds on to musical memories.

9 Mar 2005

Dental medicine is on the brink of profound change

Advances in stem cell biology will improve our understanding of degenerative diseases and assist in developing therapies for replacing damaged or diseased parts/tissues.

9 Mar 2005

Study examines consequences of Thailand's "War on Drugs"

Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand’s aggressive war on illicit drugs and the war’s impact on injection drug users.

9 Mar 2005

UN votes to ban human cloning

By a vote of 84 in favor, 34 against and 37 abstaining, with 36 absent, the UN today approved a declaration calling on all UN Member States to ban all forms of human cloning, including cloning for medical treatment, as incompatible with human dignity and the protection of human life.

9 Mar 2005

Thalidomide - new treatment for cancer

Thalidomide, famous in the 60's because of limb deformities in babies born to women who had taken it for morning sickness, was withdrawn in 1961. Now doctors say it could be used as a treatment for cancer.

8 Mar 2005

Web site offers fast access to drugs

A new web site run by pharmaceutical companies can help direct Indiana residents to prescription drug programs that offer free or discounted medications. Governor Mitch Daniels, a former executive at Eli Lilly and Company, says it's a safer alternative to importing drugs from other countries.

8 Mar 2005

HIV is not an independent risk factor for severe heart disease

Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).

8 Mar 2005

Nature of electrical abnormalities occurring during the development of heart failure

A Johns Hopkins undergraduate student has contributed to new research showing that electrical changes in the heart leading to heart failure can occur long before a patient exhibits any clinical symptoms.

8 Mar 2005

Progress toward development of a breast cancer vaccine

Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.

8 Mar 2005

Cigarette smoke worsens respiratory infections in infants

Studying Respiratory Syncytial Virus (RSV) to learn what puts children at risk for the most severe infections, Washington University researchers at St. Louis Children's Hospital found that a child's age at the time of infection and whether that child lives with a smoker could mean the difference between the sniffles and the intensive care unit.

8 Mar 2005

Biomedical engineers, chemists collaborate on novel method to design better medicines

The ability to select and develop compounds that act on specific cellular targets has just gained a computational ally -- a mathematical algorithm that predicts the precise effects a given compound will have on a cell's molecular components or chemical processes.

8 Mar 2005

Pet scanning could cut use of angiograms and bypass surgery, as well as patient costs

Using positron emission tomography (PET) scanning rather than other types of imaging as the first tool to diagnose heart-vessel blockages is more accurate, less invasive and saves dollars, a study by a University at Buffalo team has shown.

8 Mar 2005

Research News and Research

Medicaid enrollment at late stages may partly explain poor outcomes for cancer

Telomerase finding has major implications for cancer

Overlapping signals in embryo help get the backbone right

Finding may open new horizons for understanding the initiation of chemically induced cancers

New chemotherapy gives hope to brain tumour patients

Efforts to improve the quality of post-heart attack care working better for men than for women

First reliable measure of neurobehavioral functioning during coma from severe brain injury

Commonly used anesthetic regimen appears to have no negative effects on the developing brain of the fetus

Common anesthetics appear safe for developing fetal brain

Dental medicine is on the brink of profound change

Study examines consequences of Thailand's "War on Drugs"

UN votes to ban human cloning

Thalidomide - new treatment for cancer

Web site offers fast access to drugs

HIV is not an independent risk factor for severe heart disease

Nature of electrical abnormalities occurring during the development of heart failure

Progress toward development of a breast cancer vaccine

Cigarette smoke worsens respiratory infections in infants

Biomedical engineers, chemists collaborate on novel method to design better medicines

Pet scanning could cut use of angiograms and bypass surgery, as well as patient costs

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®